BluePeak Private Capital’s Investment in Africure’s Operations in Nigeria for USD 15 million

Lead party: BluePeak Private Capital (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Africure Pharmaceuticals Limited (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Burkina Faso, Tanzania, Nigeria, Namibia, Mauritius, Botswana, Côte d’Ivoire, Cameroon, Ethiopia, Zimbabwe Transaction type: Investment · Asset class: Private Equity · Strategy:…


Lead party: BluePeak Private Capital (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Africure Pharmaceuticals Limited (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Burkina Faso, Tanzania, Nigeria, Namibia, Mauritius, Botswana, Côte d’Ivoire, Cameroon, Ethiopia, Zimbabwe

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Deal amount: US$15m · Fund: BluePeak Private Capital Fund SCSp

Lead investor/buyer: BluePeak Private Capital · Investors/buyers: BluePeak Private Capital

Legal advisers: not identified in the source record.

Source: announced 26 April 2022. Original announcement: africaglobalfunds.com.